Compounds > carbostyril
Page last updated: 2024-08-17

carbostyril and gemifloxacin

carbostyril has been researched along with gemifloxacin in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, EJ1
Firsov, AA; Lubenko, IY; Portnoy, YA; Vostrov, SN; Zinner, SH1
Kinzig-Schippers, M; Kolbert, M; Machka, K; Malerczyk, C; Shah, PM; Sörgel, F1
Bébéar, C; Bébéar, CM; Pereyre, S; Renaudin, H1
Hooper, DC; Strahilevitz, J; Truong-Bolduc, QC1
Horstkotte, MA; Knobloch, JK; Mack, D; Rohde, H; Von Osten, H1
Chou, CH; Hsu, HL; Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK1
Hsueh, PR; Lee, PI; Yang, JC1
Chen, LA; Falagas, ME; Liu, YN; Matthew, FE; Wang, R; Zhang, L1
Chang, WL; Cheng, HC; Huang, AH; Kao, CY; Sheu, BS; Wu, CT; Wu, JJ; Yang, HB1
Chong, S; Chung, SJ; Jin, HE; Kim, DD; Kim, SB; Shim, CK; Shim, WS; Song, B1
Ajiboye, TO; Ibitoye, OB1

Reviews

1 review(s) available for carbostyril and gemifloxacin

ArticleYear
Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Chinese medical journal, 2012, Volume: 125, Issue:4

    Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Community-Acquired Infections; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2012

Trials

1 trial(s) available for carbostyril and gemifloxacin

ArticleYear
Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae

2004

Other Studies

10 other study(ies) available for carbostyril and gemifloxacin

ArticleYear
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters.
    Chemotherapy, 2002, Volume: 48, Issue:6

    Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Time Factors

2002
In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Naphthyridines; Quinolones

2004
DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Microbial Sensitivity Tests; Mutation; Naphthyridines; Pyrrolidines; Quinolones; Staphylococcus aureus; Topoisomerase II Inhibitors

2005
Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population.
    The International journal of artificial organs, 2008, Volume: 31, Issue:9

    Topics: Anti-Infective Agents; Aza Compounds; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Naphthyridines; Prosthesis-Related Infections; Quinolines; Quinolones; Staphylococcal Infections; Staphylococcus epidermidis

2008
Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2

    Topics: Antitubercular Agents; Fluoroquinolones; Gemifloxacin; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Quinolones; Tuberculosis

2009
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline

2010
Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Helicobacter, 2012, Volume: 17, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Naphthyridines; Quinolones; Taiwan

2012
Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.
    Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:4

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Transport; Caco-2 Cells; Dogs; Fluoroquinolones; Gemifloxacin; Humans; Inhibitory Concentration 50; Intestinal Absorption; Kinetics; Madin Darby Canine Kidney Cells; Male; Membrane Transport Proteins; Naphthyridines; Quinolones; Rats; Rats, Sprague-Dawley; Verapamil

2013
(+)-Catechin potentiates the oxidative response of Acinetobacter baumannii to quinolone-based antibiotics.
    Microbial pathogenesis, 2019, Volume: 127

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Catechin; Ciprofloxacin; Drug Synergism; Gemifloxacin; Microbial Sensitivity Tests; Oxidative Stress; Quinolones; Reactive Oxygen Species

2019